Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467896 · ClinicalTrials.gov registry record · Phase 2
The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting
A Phase 2 study, sponsored by Actelion.
- Terminated
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT00467896 is a Phase 2 study that was terminated before completion, run by Actelion. The registered enrollment target is 62 participants.
The verdict
NCT00467896, a Phase 2 study, was terminated before completion, sponsored by Actelion.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"
Interventions
- DRUG Iloprost PD-6
- DRUG Iloprost PD-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2006-09 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467896
The ClinicalTrials.gov registry entry for NCT00467896 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actelion, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iloprost PD-6 is the first listed.
NCT00467896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467896 about?
NCT00467896 is a clinical study titled "The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting". A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"
What is the current status of trial NCT00467896?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2006-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00467896?
The interventions under investigation include: Iloprost PD-6 (DRUG), Iloprost PD-15 (DRUG).
Who is sponsoring clinical trial NCT00467896?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.